Literature DB >> 8639443

Fusidic acid induced acute immunologic thrombocytopenia.

N El-Kassar1, P Kalfon, P Fromont, C Vezinet, B Godeau, N Duedari, P Bierling.   

Abstract

Fusidic acid is used in hospitals as second-line therapy for multidrug-resistant staphylococcal infections. We report the first fully documented case of fusidic acid induced thrombocytopenia, in a 48-year-old patient. The thrombocytopenia was abrupt and severe but resolved spontaneously 7 d after drug withdrawal. The thrombocytopenia transiently relapsed 6 d later, when fusidic acid was reintroduced. Haemorrhagic signs were observed, but no severe bleeding occurred. Platelet transfusions failed to increase the platelet count. We detected an IgG platelet antibody in the patient's serum, that specifically recognized platelet glycoprotein IIb/IIIa only in the presence of fusidic acid. Fusidic acid induced thrombocytopenia should be considered as a possible cause for the thrombocytopenia frequently seen in the intensive care setting.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8639443     DOI: 10.1046/j.1365-2141.1996.5211064.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  1 in total

1.  Bicytopenia in a 15-Year-Old Adolescent: A Rare Side Effect of Fusidic Acid.

Authors:  Nihan Şık; Kevser Asena Çakan Başerdem; Şefika Akyol; Özlem Tüfekçi; Durgül Yılmaz; Murat Duman
Journal:  Turk Arch Pediatr       Date:  2021-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.